Greystone Financial Group LLC购入Thermo Fisher Scientific Inc. $TMO 14,819股 - MarketBeat
14,819 Shares in Thermo Fisher Scientific Inc. $TMO Bought by Greystone Financial Group LLC - MarketBeat
生物技术与制药领域的最新动态
14,819 Shares in Thermo Fisher Scientific Inc. $TMO Bought by Greystone Financial Group LLC - MarketBeat
Characterization of RNA interference in the cnidarian Nematostella vectensis reveals partial target silencing but lack of small RNA amplification
The Rho GTPase regulator ARHGEF3 orchestrates hair placode budding by coordinating cell fate and P-cadherin patterning in mice
MMSpa is a deep learning-based tool that enhances the identification of spatial domains in spatial transcriptomics studies
Foxi1 regulates multipotent mucociliary progenitors and ionocyte specification through transcriptional and epigenetic mechanisms
Modeling of H5N1 influenza virus kinetics during dairy cattle infection suggests the timing of infectiousness
Psithera spun out of Roivant with $47.5M and immune, inflammatory focus
Novo launches Wegovy pill; Argenx to swap CEOs
Agilent Technologies (NYSE:A) Upgraded at Evercore ISI - MarketBeat
3 of China’s most innovative pharma companies
New Nav1.8 blockers disclosed in Jumpcan Pharmaceutical patent
Chinese scientists discover new NMDA and serotonin receptor antagonists
Holiday notice
Aktis Oncology eyes $181M listing to start industry’s anticipated IPO rebound
2025 by the numbers: Layoff rounds rise 16% YOY
Cash-strapped TME Pharma loses partner, prompting eye drug strategy rethink
Gateway Investment Advisers LLC Decreases Holdings in Agilent Technologies, Inc. $A - MarketBeat
Comanche gets $40M more to test its preeclampsia siRNA
Servier taps Insilico’s AI platform for early cancer R&D
Should Illumina’s (ILMN) Grail Spinoff to Ease Regulatory Pressure Require Action From Investors? - simplywall.st